{"pmid":32469426,"title":"African American children are at higher risk for COVID-19 infection.","text":["African American children are at higher risk for COVID-19 infection.","Infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral etiology of the novel coronavirus disease 2019 (COVID-19), was first reported in Wuhan, China in late 2019. Peculiarly, the virus has not caused significant impact on pediatric populations, unlike other coronaviruses (1). Children comprise only 1.7% of COVID-19 positive cases in the United States (2). Furthermore, children are noted to have a milder disease course (3, 4). However, much is unknown about the age, gender and race risk factors of COVID-19 among children. There has been recent evidence suggestive of higher rates of COVID-19 and related fatality rates in African American adult communities around the United States(5). However, there is limited data, to our knowledge, whether any race or ethnicity group is at higher risk for COVID-19 infection in children.","Pediatr Allergy Immunol","Bandi, Sindhura","Nevid, Michael Z","Mahdavinia, Mahboobeh","32469426"],"abstract":["Infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral etiology of the novel coronavirus disease 2019 (COVID-19), was first reported in Wuhan, China in late 2019. Peculiarly, the virus has not caused significant impact on pediatric populations, unlike other coronaviruses (1). Children comprise only 1.7% of COVID-19 positive cases in the United States (2). Furthermore, children are noted to have a milder disease course (3, 4). However, much is unknown about the age, gender and race risk factors of COVID-19 among children. There has been recent evidence suggestive of higher rates of COVID-19 and related fatality rates in African American adult communities around the United States(5). However, there is limited data, to our knowledge, whether any race or ethnicity group is at higher risk for COVID-19 infection in children."],"journal":"Pediatr Allergy Immunol","authors":["Bandi, Sindhura","Nevid, Michael Z","Mahdavinia, Mahboobeh"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32469426","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/pai.13298","keywords":["asthma","covid-19","pediatrics","race","risk factors"],"locations":["Wuhan","China","United States","African American","African American"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"weight":0,"_version_":1668420887235264512,"score":9.490897,"similar":[{"pmid":32382748,"title":"Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies.","text":["Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies.","The current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), reveals a peculiar trend of milder disease and lower case fatality in children compared to adults. Consistent epidemiologic evidence of reduced severity of infection in children across different populations and countries suggests there are underlying biologic differences between children and adults that mediate differential disease pathogenesis. This presents a unique opportunity to learn about disease modifying host factors from pediatric populations. Our review summarizes the current knowledge of pediatric clinical disease, role in transmission, risks for severe disease, protective immunity, as well as novel therapies and vaccine trials for children. We then define key hypotheses and areas for future research that can use the pediatric model of disease, transmission, and immunity to develop preventive and therapeutic strategies for people of all age groups.","Clin Infect Dis","Singh, Tulika","Heston, Sarah M","Langel, Stephanie N","Blasi, Maria","Hurst, Jillian H","Fouda, Genevieve G","Kelly, Matthew S","Permar, Sallie R","32382748"],"abstract":["The current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), reveals a peculiar trend of milder disease and lower case fatality in children compared to adults. Consistent epidemiologic evidence of reduced severity of infection in children across different populations and countries suggests there are underlying biologic differences between children and adults that mediate differential disease pathogenesis. This presents a unique opportunity to learn about disease modifying host factors from pediatric populations. Our review summarizes the current knowledge of pediatric clinical disease, role in transmission, risks for severe disease, protective immunity, as well as novel therapies and vaccine trials for children. We then define key hypotheses and areas for future research that can use the pediatric model of disease, transmission, and immunity to develop preventive and therapeutic strategies for people of all age groups."],"journal":"Clin Infect Dis","authors":["Singh, Tulika","Heston, Sarah M","Langel, Stephanie N","Blasi, Maria","Hurst, Jillian H","Fouda, Genevieve G","Kelly, Matthew S","Permar, Sallie R"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32382748","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1093/cid/ciaa547","keywords":["covid-19","children","pediatrics","sars-cov-2","vaccines"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1666267276777619456,"score":198.86267},{"pmid":32424745,"title":"SARS-COV-2 infection in children and newborns: a systematic review.","text":["SARS-COV-2 infection in children and newborns: a systematic review.","A recent outbreak of a novel Coronavirus responsible for a Severe Acute Respiratory Syndrome (SARS-CoV-2) is spreading globally. The aim of this study was to systematically review main clinical characteristics and outcomes of SARS-CoV-2 infections in pediatric age. An electronic search was conducted in PubMed database. Papers published between 1 January and 1 May 2020 including children aged 0-18 years were selected. Sixty-two studies and three reviews were included, with a total sample size of 7480 children (2428/4660 males, 52.1%; weighted mean age 7.6 years). Patients showed mainly mild (608/1432, 42.5%) and moderate (567/1432, 39.6%) signs of the infection. About 2% of children were admitted to the pediatric intensive care unit. The most commonly described symptoms were fever (51.6%) and cough (47.3%). Laboratory findings were often unremarkable. Children underwent a chest CT scan in 73.9% of all cases, and 32.7% resulted normal. Overall, the estimated mortality was 0.08%. A higher proportion of newborns was severely ill (12%) and dyspnea was the most common reported sign (40%).Conclusion: SARS-CoV-2 affects children less severely than adults. Laboratory and radiology findings are mainly nonspecific. Larger epidemiological and clinical cohort studies are needed to better understand possible implications of COVID-19 infection in children.What is Known:* A novel Coronavirus has been recently identified as responsible for a new Severe Acute Respiratory Syndrome (SARS-CoV-2) spreading globally.* There is limited evidence on SARS-CoV2 infection in children.What is New:* Systematically reviewed available evidence showed that children with SARS-CoV-2 infection may have a less severe pattern of disease in comparison to adults.* Blood tests and radiology findings are mainly nonspecific in children but may help to identify those who are severely ill.","Eur J Pediatr","Liguoro, Ilaria","Pilotto, Chiara","Bonanni, Margherita","Ferrari, Maria Elena","Pusiol, Anna","Nocerino, Agostino","Vidal, Enrico","Cogo, Paola","32424745"],"abstract":["A recent outbreak of a novel Coronavirus responsible for a Severe Acute Respiratory Syndrome (SARS-CoV-2) is spreading globally. The aim of this study was to systematically review main clinical characteristics and outcomes of SARS-CoV-2 infections in pediatric age. An electronic search was conducted in PubMed database. Papers published between 1 January and 1 May 2020 including children aged 0-18 years were selected. Sixty-two studies and three reviews were included, with a total sample size of 7480 children (2428/4660 males, 52.1%; weighted mean age 7.6 years). Patients showed mainly mild (608/1432, 42.5%) and moderate (567/1432, 39.6%) signs of the infection. About 2% of children were admitted to the pediatric intensive care unit. The most commonly described symptoms were fever (51.6%) and cough (47.3%). Laboratory findings were often unremarkable. Children underwent a chest CT scan in 73.9% of all cases, and 32.7% resulted normal. Overall, the estimated mortality was 0.08%. A higher proportion of newborns was severely ill (12%) and dyspnea was the most common reported sign (40%).Conclusion: SARS-CoV-2 affects children less severely than adults. Laboratory and radiology findings are mainly nonspecific. Larger epidemiological and clinical cohort studies are needed to better understand possible implications of COVID-19 infection in children.What is Known:* A novel Coronavirus has been recently identified as responsible for a new Severe Acute Respiratory Syndrome (SARS-CoV-2) spreading globally.* There is limited evidence on SARS-CoV2 infection in children.What is New:* Systematically reviewed available evidence showed that children with SARS-CoV-2 infection may have a less severe pattern of disease in comparison to adults.* Blood tests and radiology findings are mainly nonspecific in children but may help to identify those who are severely ill."],"journal":"Eur J Pediatr","authors":["Liguoro, Ilaria","Pilotto, Chiara","Bonanni, Margherita","Ferrari, Maria Elena","Pusiol, Anna","Nocerino, Agostino","Vidal, Enrico","Cogo, Paola"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32424745","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s00431-020-03684-7","keywords":["covid-19","infectious disease","neonatal","novel coronavirus","pandemic","pediatrics"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667352728700977152,"score":166.0905},{"pmid":32435809,"title":"Racial demographics and COVID-19 confirmed cases and deaths: a correlational analysis of 2886 US counties.","text":["Racial demographics and COVID-19 confirmed cases and deaths: a correlational analysis of 2886 US counties.","BACKGROUND: Recent news reports state that racial minority groups, such as African-Americans, are experiencing a greater COVID-19 burden, as measured by confirmed cases and deaths. Limited racial data is available on a national level. METHODS: We conducted the first nationwide analysis to examine COVID-19 and race on a county level. We obtained datasets on COVID-19 cases and deaths, and racial population totals, by US county. We examined if correlations exist between the racial percentages and percentages of confirmed COVID-19 cases and deaths by county. RESULTS: A positive correlation existed between percentages of African-Americans living in a county and who have COVID-19 (r = 0.254, P < 0.0001), who have died from COVID-19 (r = 0.268, P < 0.0001), and case mortality (r = 0.055, P = 0.003). Positive correlations also existed between percentages of Asian-Americans living in counties and these factors. Negative correlations existed between percentages of Whites living in counties and these factors. CONCLUSIONS: A weak, albeit very significant, positive relationship exists between the percentage of African-Americans living in a county and the percentage of COVID-19 confirmed cases, confirmed deaths and case mortality in the county. This is in support of many city and statewide analyses, and we urge for targeted resources towards work that further examine these racial associations.","J Public Health (Oxf)","Mahajan, Uma V","Larkins-Pettigrew, Margaret","32435809"],"abstract":["BACKGROUND: Recent news reports state that racial minority groups, such as African-Americans, are experiencing a greater COVID-19 burden, as measured by confirmed cases and deaths. Limited racial data is available on a national level. METHODS: We conducted the first nationwide analysis to examine COVID-19 and race on a county level. We obtained datasets on COVID-19 cases and deaths, and racial population totals, by US county. We examined if correlations exist between the racial percentages and percentages of confirmed COVID-19 cases and deaths by county. RESULTS: A positive correlation existed between percentages of African-Americans living in a county and who have COVID-19 (r = 0.254, P < 0.0001), who have died from COVID-19 (r = 0.268, P < 0.0001), and case mortality (r = 0.055, P = 0.003). Positive correlations also existed between percentages of Asian-Americans living in counties and these factors. Negative correlations existed between percentages of Whites living in counties and these factors. CONCLUSIONS: A weak, albeit very significant, positive relationship exists between the percentage of African-Americans living in a county and the percentage of COVID-19 confirmed cases, confirmed deaths and case mortality in the county. This is in support of many city and statewide analyses, and we urge for targeted resources towards work that further examine these racial associations."],"journal":"J Public Health (Oxf)","authors":["Mahajan, Uma V","Larkins-Pettigrew, Margaret"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32435809","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1093/pubmed/fdaa070","keywords":["african-americans","covid-19","county","disparities","race","socioeconomics"],"locations":["African-Americans","US county","African-Americans","Asian-Americans","African-Americans","US"],"countries":["United States"],"countries_codes":["USA|United States"],"weight":0,"_version_":1667521393768529920,"score":164.49123},{"pmid":32271728,"pmcid":"PMC7147903","title":"Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.","text":["Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.","As of April 2, 2020, the coronavirus disease 2019 (COVID-19) pandemic has resulted in >890,000 cases and >45,000 deaths worldwide, including 239,279 cases and 5,443 deaths in the United States (1,2). In the United States, 22% of the population is made up of infants, children, and adolescents aged <18 years (children) (3). Data from China suggest that pediatric COVID-19 cases might be less severe than cases in adults and that children might experience different symptoms than do adults (4,5); however, disease characteristics among pediatric patients in the United States have not been described. Data from 149,760 laboratory-confirmed COVID-19 cases in the United States occurring during February 12-April 2, 2020 were analyzed. Among 149,082 (99.6%) reported cases for which age was known, 2,572 (1.7%) were among children aged <18 years. Data were available for a small proportion of patients on many important variables, including symptoms (9.4%), underlying conditions (13%), and hospitalization status (33%). Among those with available information, 73% of pediatric patients had symptoms of fever, cough, or shortness of breath compared with 93% of adults aged 18-64 years during the same period; 5.7% of all pediatric patients, or 20% of those for whom hospitalization status was known, were hospitalized, lower than the percentages hospitalized among all adults aged 18-64 years (10%) or those with known hospitalization status (33%). Three deaths were reported among the pediatric cases included in this analysis. These data support previous findings that children with COVID-19 might not have reported fever or cough as often as do adults (4). Whereas most COVID-19 cases in children are not severe, serious COVID-19 illness resulting in hospitalization still occurs in this age group. Social distancing and everyday preventive behaviors remain important for all age groups as patients with less serious illness and those without symptoms likely play an important role in disease transmission (6,7).","MMWR Morb Mortal Wkly Rep","32271728"],"abstract":["As of April 2, 2020, the coronavirus disease 2019 (COVID-19) pandemic has resulted in >890,000 cases and >45,000 deaths worldwide, including 239,279 cases and 5,443 deaths in the United States (1,2). In the United States, 22% of the population is made up of infants, children, and adolescents aged <18 years (children) (3). Data from China suggest that pediatric COVID-19 cases might be less severe than cases in adults and that children might experience different symptoms than do adults (4,5); however, disease characteristics among pediatric patients in the United States have not been described. Data from 149,760 laboratory-confirmed COVID-19 cases in the United States occurring during February 12-April 2, 2020 were analyzed. Among 149,082 (99.6%) reported cases for which age was known, 2,572 (1.7%) were among children aged <18 years. Data were available for a small proportion of patients on many important variables, including symptoms (9.4%), underlying conditions (13%), and hospitalization status (33%). Among those with available information, 73% of pediatric patients had symptoms of fever, cough, or shortness of breath compared with 93% of adults aged 18-64 years during the same period; 5.7% of all pediatric patients, or 20% of those for whom hospitalization status was known, were hospitalized, lower than the percentages hospitalized among all adults aged 18-64 years (10%) or those with known hospitalization status (33%). Three deaths were reported among the pediatric cases included in this analysis. These data support previous findings that children with COVID-19 might not have reported fever or cough as often as do adults (4). Whereas most COVID-19 cases in children are not severe, serious COVID-19 illness resulting in hospitalization still occurs in this age group. Social distancing and everyday preventive behaviors remain important for all age groups as patients with less serious illness and those without symptoms likely play an important role in disease transmission (6,7)."],"journal":"MMWR Morb Mortal Wkly Rep","date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271728","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.15585/mmwr.mm6914e4","locations":["United States","United States","China","United States","United States"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"topics":["Diagnosis","Prevention"],"weight":1,"_version_":1666138491815198721,"score":158.40208},{"pmid":32324118,"title":"Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.","text":["Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.","We estimated that 45.4% of US adults are at increased risk for complications from coronavirus disease because of cardiovascular disease, diabetes, respiratory disease, hypertension, or cancer. Rates increased by age, from 19.8% for persons 18-29 years of age to 80.7% for persons >80 years of age, and varied by state, race/ethnicity, health insurance status, and employment.","Emerg Infect Dis","Adams, Mary L","Katz, David L","Grandpre, Joseph","32324118"],"abstract":["We estimated that 45.4% of US adults are at increased risk for complications from coronavirus disease because of cardiovascular disease, diabetes, respiratory disease, hypertension, or cancer. Rates increased by age, from 19.8% for persons 18-29 years of age to 80.7% for persons >80 years of age, and varied by state, race/ethnicity, health insurance status, and employment."],"journal":"Emerg Infect Dis","authors":["Adams, Mary L","Katz, David L","Grandpre, Joseph"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324118","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.3201/eid2608.200679","keywords":["covid-19","sars-cov-2","united states","chronic conditions","complications","coronavirus disease","infection","population-based estimates","respiratory infections","risk factors","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["US","Coronavirus Disease","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1666138493921787904,"score":152.44751}]}